Bromodeoxyuridine incorporation and Ki 67 expression in oral hairy leukoplakia

Oral Diseases

Volumn 4, Issue 1, 1998, Pages 9-15

  Cruchley, A T ^a   De Souza, Y G ^b   Williams, D M ^a   Greenspan, D ^b   Greenspan, J S ^b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bromodeoxyuridine; Cell turnover; Epstein Barr virus; Keratinocytes; Ki 67; Oral hairy leukoplakia

Indexed keywords

BROXURIDINE; KI 67 ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LEUKOPLAKIA; MALE; PRIORITY JOURNAL; VIRUS REPLICATION;

EID: 0031667567     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.1998.tb00248.x     Document Type: Article

References (39)

1. Allday MJ, Sinclair A, Parker G et al (1995). Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53. EMBO J 14: 1382-1391.
2. Bauer G, Gotschl M, Hofler P (1991). Tumor-promoting activity of Epstein-Barr-virus-inducing factor transforming growth factor type beta (EIF/TGF-beta) is due to the induction of irreversible transformation. Int J Cancer 47: 881-888.
3. Bende RJ, Jochems GJ, Frame TH et al (1992). Effects of IL-4, IL-5, and IL-6 on growth and immunoglobulin production of Epstein-Barr virus-infected human B cells. Cell Immunol 143: 310-323.
4. Brysk MM, Bell T, Tyring SK et al (1994). Cytokines modulate terminal differentiation and the expression of predesquamin in cultured keratinocytes. Exp Cell Res 211: 49-52
5. Brysk MM. Santschi C, Bell T et al (1993). Predesquamin inhibits desquamation. Exp Cell Res 209: 301-306.
6. Brysk MM, Selvanayagam P, Arany I et al (1995). Induction of apoptotic nuclei by interferon-gamma and by predesquamin in cultured keratinocytes. J Interferon & Cytokine Res 15: 1029-1035.
7. Chrysomali E, Greenspan JS. Dekker N et al (1996). Apoptosis-associated proteins in oral hairy leukoplakia. Oral Dis 2: 279-284.
8. Corso B, Eversole Lr. Hutt-Fletcher L (1989). Hairy leukoplakia: Epstein-Barr virus receptors on oral keratinocyte plasma membranes. Oral Surg Oral Med Oral Pathol 67: 416-421.
9. Dawson CW, Eliopoulos AG, Dawson J et al (1995). BHRF1, a viral homologue of the Bc1-2 oncogene, disturbs epithelial cell differentiation. Oncogene 10: 69-77.
10. Dawson CW, Rickinson AB, Young LS (1990). Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 344: 777-780.
11. de Waal Malefyt R, Haanen J, Spits H et al (1991). Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigenpresenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174: 915-924.
12. Fahraeus R, Chen W, Trivedi P et al (1992). Decreased expression of E-cadherin and increased invasive capacity in EBV-LMP-transfected human epithelial and murine adenocarcinoma cells. Int J Cancer 52: 834-838.
13. Fahraeus R, Rymo L, Rhim JS et al (1990). Morphological transformation of human keratinocytes expressing the LMP gene of Epstein Barr virus. Nature 345: 447-449.
14. Greenspan D, Greenspan JS (1992). Significance of oral hairy leukoplakia. Oral Surg Oral Med Oral Pathol 73: 151-154
15. Greenspan JS, Greenspan D, Lennette ET et al (1985) Replication of Epstein-Barr virus within the epithelial cells of oral 'hairy' leukoplakia, an AIDS-associated lesion. New Engl J Med 313: 1564-1571.
16. Hall PA, Levison DA (1990). Review: assessment of cell proliferation in histological material. J Clin Pathol 43: 184-192.
17. Hickish T, Robertson D, Clarke P et al (1994). Ultrastructural localization of BHRF1: an Epstein-Barr virus gene product which has homology with bc1-2. Cancer Res 54: 2808-2811.
18. Ho AS, Moore KW (1994). Interleukin-10 and its receptor. Ther Immunol 1: 173-185.
19. Hume WJ (1989). DNA-synthesizing cells in oral epithelium have a range of cycle durations: evidence from double-labelling studies using tritiated thymidine and bromodeoxyuridine. Cell Tissue Kinet 22: 377-382.
20. Li J, Farthing PM. Ireland GW et al (1996a). Il-lα and Il-6 production by oral and skin keratinocytes: similarities and differences in response to cytokine treatment in vitro. J Oral Pathol Med 25: 157-62.
21. Li J, Ireland GW, Farthing PM et al (1996b). Epidermal and oral keratinocytes are induced to produce RANTES and IL-8 by cytokine stimulation. J Invest Dermatol 106: 661-666.
22. Li QX, Young LS, Niedobitek G et al (1992). Epstein Barr virus infection and replication in a human epithelial cell system. Nature 356: 347-350.
23. Luger TA, Schwarz T (1990). Evidence for an epidermal cytokine network. J Invest Dermatol 95: 100s-104s.
24. Maden C, Hopkins SG, Lafferty WE (1994). Progression to AIDS or death following diagnosis with a class IV non-AIDS disease: utilization of a surveillance database. J Acquir Immune Defic Syndr 7: 972-977.
25. Miller MA, Mazewski CM, Yousuf N et al (1991). Simultaneous immunohistochemical detection of IUdr and brdU infused intravenously to cancer patients. J Histochem Cytochem 39: 407-412.
26. Niedobitek G, Young LS (1994). Epstein-Barr-virus persistence and virus-associated tumors. Lancet 343: 333-335.
27. Roncella S, Baldi L, Cutrona G et al (1995). Production of inflammatory cytokines by Epstein-Barr virus (EBV)-infected lymphoblastoid cell lines spontaneously originated from the peripheral blood of patients with human immunodeficiency virus (HIV) infection. Clin Immunol Immunopathol 77: 162-171.
28. Sawhney N, Hall PA (1992). Ki 67 - structure, function and new antibodies. J Pathol 168: 161-162.
29. Su L, Morgan PR, Thomas JA et al (1993). Expression of keratin 14 and 19 mRNA and protein in normal oral epithelia, hairy leukoplakia, tongue biting and white sponge nevus. J Oral Pathol Med 22: 183-189.
30. Suzuki Y, Koyama J, Moro O et al (1996). The role of two endogenous proteases of the stratum corneum in degradation of desmoglein-1 and their reduced activity in the skin of ichthyotic patients. Br J Dermatol 134: 460-464.
31. Suzuki Y, Nomura J, Koyama J et al (1994). The role of proteases in stratum corneum: involvement in stratum corneum desquamation. Arch Dermatol Res 286: 249-253.
32. Takimoto T, Tanaka S, Ishikawa S et al (1989). Further studies on growth characteristics of Epstein-Barr virus (EBV) genome-positive and -negative epithelial hybrid cell lines. Laryngoscope 99: 741-743.
33. Talacko AA, Teo CG, Griffin BE et al (1991). Epstein-Barr virus receptors but not viral DNA are present in normal and malignant oral epithelium. J Oral Pathol Med 20: 20-25.
34. Thomas JA, Felix DH, Wray D et al (1991). Epstein-Barr virus gene expression and epithelial cell differentiation in oral hairy leukoplakia. Am J Pathol 139: 1369-1380.
35. Thomton JG, Wells M. Hume WJ (1988). Flash labelling of Sphase cells in short-term organ culture of normal and pathological human endometrium using bromodeoxyuridine and tritiated thymidine. J Pathol 154: 321-328.
36. Warnakulasuriya KAAS. MacDonald DG (1995). Epithelial cell kinetics in oral leukoplakia. J Oral Pathol Med 24: 165-169.
37. Whittingham S, Naselli G, Harrison LC et al (1993). Cytokine production in response to Epstein-Barr virus infection of peripheral blood mononuclear cells in vitro. Immunol Cell Biol 71: 259-264.
38. Williams DM, Leigh IM. Greenspan D et al (1991). Altered patterns of keratin expression in oral hairy leukoplakia. J Oral Pathol Med 20: 167-171.
39. Young LS, Lau R, Rowe M et al (1991). Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J Virol 65: 2868-2874.